Loading...
XKRX001630
Market cap153mUSD
Jan 03, Last price  
47,500.00KRW
1D
0.11%
1Q
-16.52%
Jan 2017
-31.06%
Name

Chongkundang Holdings Corp

Chart & Performance

D1W1MN
XKRX:001630 chart
P/E
4.81
P/S
0.26
EPS
9,874.37
Div Yield, %
4.44%
Shrs. gr., 5y
-0.75%
Rev. gr., 5y
10.62%
Revenues
879.78b
-3.21%
316,994,408,000381,590,415,000452,468,204,000526,719,224,000569,163,668,370595,433,637,000560,617,589,230181,395,445,260221,832,028,450335,675,556,280450,735,117,690531,114,469,560720,644,043,390858,118,780,740925,975,076,420908,962,764,130879,780,769,940
Net income
47.01b
P
19,860,342,00021,644,398,00025,689,300,00044,245,454,00053,526,155,00032,007,503,060415,737,872,5109,460,624,35015,207,835,36029,431,339,66048,009,132,93027,457,239,95079,329,792,650113,621,663,10025,824,890,410-22,663,808,79047,007,481,869
CFO
37.15b
P
15,060,432,00027,277,210,00036,055,001,00062,860,783,00052,764,269,22057,886,787,74050,792,120,6403,621,197,4008,228,337,62019,403,614,39057,767,652,91037,931,092,400111,279,403,52066,553,214,34040,460,131,600-46,501,658,05037,146,789,180
Dividend
Dec 27, 20231400 KRW/sh
Earnings
Feb 11, 2025

Profile

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is headquartered in Seoul, South Korea.
URL
http://www.ckdpharm.com/
IPO date
Jun 30, 1976
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
879,780,770
-3.21%
908,962,764
-1.84%
Cost of revenue
776,718,224
864,253,056
Unusual Expense (Income)
NOPBT
103,062,546
44,709,709
NOPBT Margin
11.71%
4.92%
Operating Taxes
3,130,248
(2,044,464)
Tax Rate
3.04%
NOPAT
99,932,298
46,754,172
Net income
47,007,482
-307.41%
(22,663,809)
-187.76%
Dividends
(10,042,043)
(10,393,502)
Dividend yield
3.52%
4.00%
Proceeds from repurchase of equity
(5,346,849)
(5,061,383)
BB yield
1.87%
1.95%
Debt
Debt current
393,595,700
287,980,730
Long-term debt
80,068,961
143,850,446
Deferred revenue
Other long-term liabilities
11,142,671
10,536,483
Net debt
(89,196,883)
58,637,823
Cash flow
Cash from operating activities
37,146,789
(46,501,658)
CAPEX
(32,076,395)
(65,270,180)
Cash from investing activities
(23,994,763)
(64,690,796)
Cash from financing activities
(4,132,063)
67,041,297
FCF
80,781,924
(13,793,547)
Balance
Cash
81,155,523
82,808,240
Long term investments
481,706,021
290,385,112
Excess cash
518,872,505
327,745,214
Stockholders' equity
673,180,576
696,574,785
Invested Capital
783,788,805
907,615,695
ROIC
11.82%
5.30%
ROCE
7.75%
3.54%
EV
Common stock shares outstanding
4,824
4,905
Price
59,200.00
11.70%
53,000.00
-30.72%
Market cap
285,598,619
9.85%
259,979,469
-31.75%
EV
456,936,111
588,295,496
EBITDA
148,342,277
87,652,533
EV/EBITDA
3.08
6.71
Interest
19,603,059
10,803,259
Interest/NOPBT
19.02%
24.16%